{"transactions":[{"id":770176,"issuer":{"id":2704,"kind":"organization","name":"AtriCure, Inc.","symbol":"ATRC"},"owners":[{"id":15049,"kind":"person","name":"Telman Deborah H","position":1,"cik":"0001860008","reported_name":"Telman Deborah H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-20T16:33:47.000Z","date":"2026-05-18","kind":"grant","planned":false,"acquired":true,"shares":6144,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2023 Stock Incentive Plan. The shares will vest upon the one-year anniversary of the grant date."}],"balance_after":28328,"source":{"system":"sec-edgar","filing":"0001860008-26-000002","document":"wk-form4_1779294824.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1860008/000186000826000002/wk-form4_1779294824.xml","form_type":"4"}},{"id":317166,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15049,"kind":"person","name":"Telman Deborah H","position":1,"cik":"0001860008","reported_name":"Telman Deborah H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Corporate Affairs & GC"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2025-11-14T00:36:11.000Z","date":"2025-11-12","kind":"exercise","planned":true,"acquired":false,"shares":500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in the Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on August 13, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock options have a four-year vesting schedule.  25% vest on the first anniversary of the date of grant.  The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":12155,"derivative":{"exercise_price":60.75,"expiration_date":"2032-07-25","underlying":"Common Stock","underlying_shares":500},"source":{"system":"sec-edgar","filing":"0001860008-25-000009","document":"wk-form4_1763080568.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/882095/000186000825000009/wk-form4_1763080568.xml","form_type":"4"}},{"id":317165,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15049,"kind":"person","name":"Telman Deborah H","position":1,"cik":"0001860008","reported_name":"Telman Deborah H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Corporate Affairs & GC"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2025-11-14T00:36:11.000Z","date":"2025-11-12","kind":"exercise","planned":true,"acquired":false,"shares":35965,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in the Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on August 13, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock options have a four-year vesting schedule.  25% vest on the first anniversary of the date of grant.  The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":12655,"derivative":{"exercise_price":60.75,"expiration_date":"2032-07-25","underlying":"Common Stock","underlying_shares":35965},"source":{"system":"sec-edgar","filing":"0001860008-25-000009","document":"wk-form4_1763080568.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/882095/000186000825000009/wk-form4_1763080568.xml","form_type":"4"}},{"id":317164,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15049,"kind":"person","name":"Telman Deborah H","position":1,"cik":"0001860008","reported_name":"Telman Deborah H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Corporate Affairs & GC"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2025-11-14T00:36:11.000Z","date":"2025-11-12","kind":"exercise","planned":true,"acquired":false,"shares":17181,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in the Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on August 13, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock options have a four-year vesting schedule.  25% vest on the first anniversary of the date of grant.  The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":37799,"derivative":{"exercise_price":75.12,"expiration_date":"2034-03-10","underlying":"Common Stock","underlying_shares":17181},"source":{"system":"sec-edgar","filing":"0001860008-25-000009","document":"wk-form4_1763080568.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/882095/000186000825000009/wk-form4_1763080568.xml","form_type":"4"}},{"id":317163,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15049,"kind":"person","name":"Telman Deborah H","position":1,"cik":"0001860008","reported_name":"Telman Deborah H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Corporate Affairs & GC"}}],"security":"Common Stock","published_at":"2025-11-14T00:36:11.000Z","date":"2025-11-12","kind":"sale","planned":true,"acquired":false,"shares":500,"price":122.904,"value":61452.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in the Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on August 13, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Sales prices for the transactions reported here range from $122.88 to $122.92.  Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request."}],"balance_after":43676,"source":{"system":"sec-edgar","filing":"0001860008-25-000009","document":"wk-form4_1763080568.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/882095/000186000825000009/wk-form4_1763080568.xml","form_type":"4"}},{"id":317162,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15049,"kind":"person","name":"Telman Deborah H","position":1,"cik":"0001860008","reported_name":"Telman Deborah H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Corporate Affairs & GC"}}],"security":"Common Stock","published_at":"2025-11-14T00:36:11.000Z","date":"2025-11-12","kind":"exercise","planned":true,"acquired":true,"shares":500,"price":60.75,"value":30375.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in the Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on August 13, 2025."}],"balance_after":44176,"source":{"system":"sec-edgar","filing":"0001860008-25-000009","document":"wk-form4_1763080568.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/882095/000186000825000009/wk-form4_1763080568.xml","form_type":"4"}},{"id":317161,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15049,"kind":"person","name":"Telman Deborah H","position":1,"cik":"0001860008","reported_name":"Telman Deborah H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Corporate Affairs & GC"}}],"security":"Common Stock","published_at":"2025-11-14T00:36:11.000Z","date":"2025-11-12","kind":"sale","planned":true,"acquired":false,"shares":35965,"price":122.302,"value":4398591.43,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in the Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on August 13, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Sales prices for the transactions reported here range from $121.87 to $122.83.  Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request."}],"balance_after":43676,"source":{"system":"sec-edgar","filing":"0001860008-25-000009","document":"wk-form4_1763080568.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/882095/000186000825000009/wk-form4_1763080568.xml","form_type":"4"}},{"id":317160,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15049,"kind":"person","name":"Telman Deborah H","position":1,"cik":"0001860008","reported_name":"Telman Deborah H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Corporate Affairs & GC"}}],"security":"Common Stock","published_at":"2025-11-14T00:36:11.000Z","date":"2025-11-12","kind":"exercise","planned":true,"acquired":true,"shares":35965,"price":60.75,"value":2184873.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in the Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on August 13, 2025."}],"balance_after":79641,"source":{"system":"sec-edgar","filing":"0001860008-25-000009","document":"wk-form4_1763080568.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000186000825000009/wk-form4_1763080568.xml","form_type":"4"}},{"id":317159,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15049,"kind":"person","name":"Telman Deborah H","position":1,"cik":"0001860008","reported_name":"Telman Deborah H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Corporate Affairs & GC"}}],"security":"Common Stock","published_at":"2025-11-14T00:36:11.000Z","date":"2025-11-12","kind":"sale","planned":true,"acquired":false,"shares":17181,"price":124,"value":2130444.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in the Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on August 13, 2025."}],"balance_after":43676,"source":{"system":"sec-edgar","filing":"0001860008-25-000009","document":"wk-form4_1763080568.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000186000825000009/wk-form4_1763080568.xml","form_type":"4"}},{"id":317158,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15049,"kind":"person","name":"Telman Deborah H","position":1,"cik":"0001860008","reported_name":"Telman Deborah H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Corporate Affairs & GC"}}],"security":"Common Stock","published_at":"2025-11-14T00:36:11.000Z","date":"2025-11-12","kind":"exercise","planned":true,"acquired":true,"shares":17181,"price":75.12,"value":1290636.72,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in the Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on August 13, 2025."}],"balance_after":60857,"source":{"system":"sec-edgar","filing":"0001860008-25-000009","document":"wk-form4_1763080568.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000186000825000009/wk-form4_1763080568.xml","form_type":"4"}},{"id":317647,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15049,"kind":"person","name":"Telman Deborah H","position":1,"cik":"0001860008","reported_name":"Telman Deborah H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Corporate Affairs & GC"}}],"security":"Restricted Stock Unit","published_at":"2025-10-27T23:43:51.000Z","date":"2025-10-25","kind":"exercise","planned":false,"acquired":false,"shares":515,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":19816,"derivative":{"underlying":"Common Stock","underlying_shares":515},"source":{"system":"sec-edgar","filing":"0001860008-25-000007","document":"wk-form4_1761608628.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000186000825000007/wk-form4_1761608628.xml","form_type":"4"}},{"id":317646,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15049,"kind":"person","name":"Telman Deborah H","position":1,"cik":"0001860008","reported_name":"Telman Deborah H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Corporate Affairs & GC"}}],"security":"Common Stock","published_at":"2025-10-27T23:43:51.000Z","date":"2025-10-25","kind":"tax_withholding","planned":false,"acquired":false,"shares":241,"price":120.94,"value":29146.54,"ownership":{"direct":true},"balance_after":43676,"source":{"system":"sec-edgar","filing":"0001860008-25-000007","document":"wk-form4_1761608628.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000186000825000007/wk-form4_1761608628.xml","form_type":"4"}},{"id":317645,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15049,"kind":"person","name":"Telman Deborah H","position":1,"cik":"0001860008","reported_name":"Telman Deborah H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Corporate Affairs & GC"}}],"security":"Common Stock","published_at":"2025-10-27T23:43:51.000Z","date":"2025-10-25","kind":"exercise","planned":false,"acquired":true,"shares":515,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."}],"balance_after":43917,"source":{"system":"sec-edgar","filing":"0001860008-25-000007","document":"wk-form4_1761608628.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000186000825000007/wk-form4_1761608628.xml","form_type":"4"}},{"id":318901,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15049,"kind":"person","name":"Telman Deborah H","position":1,"cik":"0001860008","reported_name":"Telman Deborah H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Corporate Affairs & GC"}}],"security":"Restricted Stock Unit","published_at":"2025-09-11T23:31:37.000Z","date":"2025-09-10","kind":"exercise","planned":false,"acquired":false,"shares":1315,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":20331,"derivative":{"underlying":"Common Stock","underlying_shares":1315},"source":{"system":"sec-edgar","filing":"0001860008-25-000005","document":"wk-form4_1757633494.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000186000825000005/wk-form4_1757633494.xml","form_type":"4"}},{"id":318900,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15049,"kind":"person","name":"Telman Deborah H","position":1,"cik":"0001860008","reported_name":"Telman Deborah H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Corporate Affairs & GC"}}],"security":"Common Stock","published_at":"2025-09-11T23:31:37.000Z","date":"2025-09-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":634,"price":115.25,"value":73068.5,"ownership":{"direct":true},"balance_after":43402,"source":{"system":"sec-edgar","filing":"0001860008-25-000005","document":"wk-form4_1757633494.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000186000825000005/wk-form4_1757633494.xml","form_type":"4"}},{"id":318899,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15049,"kind":"person","name":"Telman Deborah H","position":1,"cik":"0001860008","reported_name":"Telman Deborah H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Corporate Affairs & GC"}}],"security":"Common Stock","published_at":"2025-09-11T23:31:37.000Z","date":"2025-09-10","kind":"exercise","planned":false,"acquired":true,"shares":1315,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."}],"balance_after":44036,"source":{"system":"sec-edgar","filing":"0001860008-25-000005","document":"wk-form4_1757633494.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000186000825000005/wk-form4_1757633494.xml","form_type":"4"}},{"id":320361,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15049,"kind":"person","name":"Telman Deborah H","position":1,"cik":"0001860008","reported_name":"Telman Deborah H","relationship":{"officer":true,"officer_title":"EVP, Corporate Affairs & GC"}}],"security":"Restricted Stock Unit","published_at":"2025-07-28T21:10:48.000Z","date":"2025-07-25","kind":"exercise","planned":false,"acquired":false,"shares":8229,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units have a three-year vesting schedule. 33.33% will vest on each yearly anniversary of the date of the grant until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units have a three-year vesting schedule. 33.33% will vest on each yearly anniversary of the date of the grant until fully vested."}],"balance_after":21646,"derivative":{"underlying":"Common Stock","underlying_shares":8229},"source":{"system":"sec-edgar","filing":"0001127602-25-019654","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760225019654/form4.xml","form_type":"4"}},{"id":320360,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15049,"kind":"person","name":"Telman Deborah H","position":1,"cik":"0001860008","reported_name":"Telman Deborah H","relationship":{"officer":true,"officer_title":"EVP, Corporate Affairs & GC"}}],"security":"Restricted Stock Unit","published_at":"2025-07-28T21:10:48.000Z","date":"2025-07-25","kind":"exercise","planned":false,"acquired":false,"shares":514,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant.  The balance will vest 6.25% quarterly thereafter until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant.  The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":29875,"derivative":{"underlying":"Common Stock","underlying_shares":514},"source":{"system":"sec-edgar","filing":"0001127602-25-019654","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760225019654/form4.xml","form_type":"4"}},{"id":320359,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15049,"kind":"person","name":"Telman Deborah H","position":1,"cik":"0001860008","reported_name":"Telman Deborah H","relationship":{"officer":true,"officer_title":"EVP, Corporate Affairs & GC"}}],"security":"Common Stock","published_at":"2025-07-28T21:10:48.000Z","date":"2025-07-25","kind":"tax_withholding","planned":false,"acquired":false,"shares":3823,"price":116.2,"value":444232.6,"ownership":{"direct":true},"balance_after":42721,"source":{"system":"sec-edgar","filing":"0001127602-25-019654","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760225019654/form4.xml","form_type":"4"}},{"id":320358,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15049,"kind":"person","name":"Telman Deborah H","position":1,"cik":"0001860008","reported_name":"Telman Deborah H","relationship":{"officer":true,"officer_title":"EVP, Corporate Affairs & GC"}}],"security":"Common Stock","published_at":"2025-07-28T21:10:48.000Z","date":"2025-07-25","kind":"exercise","planned":false,"acquired":true,"shares":8229,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."}],"balance_after":46544,"source":{"system":"sec-edgar","filing":"0001127602-25-019654","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760225019654/form4.xml","form_type":"4"}},{"id":320357,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15049,"kind":"person","name":"Telman Deborah H","position":1,"cik":"0001860008","reported_name":"Telman Deborah H","relationship":{"officer":true,"officer_title":"EVP, Corporate Affairs & GC"}}],"security":"Common Stock","published_at":"2025-07-28T21:10:48.000Z","date":"2025-07-25","kind":"exercise","planned":false,"acquired":true,"shares":514,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."}],"balance_after":38315,"source":{"system":"sec-edgar","filing":"0001127602-25-019654","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760225019654/form4.xml","form_type":"4"}},{"id":321518,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15049,"kind":"person","name":"Telman Deborah H","position":1,"cik":"0001860008","reported_name":"Telman Deborah H","relationship":{"officer":true,"officer_title":"EVP, Corporate Affairs & GC"}}],"security":"Restricted Stock Unit","published_at":"2025-06-11T23:01:05.000Z","date":"2025-06-10","kind":"exercise","planned":false,"acquired":false,"shares":1313,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":30389,"derivative":{"underlying":"Common Stock","underlying_shares":1313},"source":{"system":"sec-edgar","filing":"0001127602-25-017337","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760225017337/form4.xml","form_type":"4"}},{"id":321517,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15049,"kind":"person","name":"Telman Deborah H","position":1,"cik":"0001860008","reported_name":"Telman Deborah H","relationship":{"officer":true,"officer_title":"EVP, Corporate Affairs & GC"}}],"security":"Common Stock","published_at":"2025-06-11T23:01:05.000Z","date":"2025-06-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":430,"price":110.09,"value":47338.7,"ownership":{"direct":true},"balance_after":37801,"source":{"system":"sec-edgar","filing":"0001127602-25-017337","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760225017337/form4.xml","form_type":"4"}},{"id":321516,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15049,"kind":"person","name":"Telman Deborah H","position":1,"cik":"0001860008","reported_name":"Telman Deborah H","relationship":{"officer":true,"officer_title":"EVP, Corporate Affairs & GC"}}],"security":"Common Stock","published_at":"2025-06-11T23:01:05.000Z","date":"2025-06-10","kind":"exercise","planned":false,"acquired":true,"shares":1313,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."}],"balance_after":38231,"source":{"system":"sec-edgar","filing":"0001127602-25-017337","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760225017337/form4.xml","form_type":"4"}},{"id":1139134,"issuer":{"id":2704,"kind":"organization","name":"AtriCure, Inc.","symbol":"ATRC"},"owners":[{"id":15049,"kind":"person","name":"Telman Deborah H","position":1,"cik":"0001860008","reported_name":"Telman Deborah H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-21T20:41:51.000Z","date":"2025-05-19","kind":"grant","planned":false,"acquired":true,"shares":5401,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2023 Stock Incentive Plan. The shares will vest upon the one-year anniversary of the grant date."}],"balance_after":22184,"source":{"system":"sec-edgar","filing":"0001323885-25-000059","document":"wk-form4_1747860104.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1860008/000132388525000059/wk-form4_1747860104.xml","form_type":"4"}},{"id":322771,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15049,"kind":"person","name":"Telman Deborah H","position":1,"cik":"0001860008","reported_name":"Telman Deborah H","relationship":{"officer":true,"officer_title":"EVP, Corporate Affairs & GC"}}],"security":"Restricted Stock Unit","published_at":"2025-04-28T17:24:48.000Z","date":"2025-04-25","kind":"exercise","planned":false,"acquired":false,"shares":514,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":31702,"derivative":{"underlying":"Common Stock","underlying_shares":514},"source":{"system":"sec-edgar","filing":"0001127602-25-012668","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760225012668/form4.xml","form_type":"4"}},{"id":322770,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15049,"kind":"person","name":"Telman Deborah H","position":1,"cik":"0001860008","reported_name":"Telman Deborah H","relationship":{"officer":true,"officer_title":"EVP, Corporate Affairs & GC"}}],"security":"Common Stock","published_at":"2025-04-28T17:24:48.000Z","date":"2025-04-25","kind":"tax_withholding","planned":false,"acquired":false,"shares":158,"price":103.17,"value":16300.86,"ownership":{"direct":true},"balance_after":36918,"source":{"system":"sec-edgar","filing":"0001127602-25-012668","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760225012668/form4.xml","form_type":"4"}},{"id":322769,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15049,"kind":"person","name":"Telman Deborah H","position":1,"cik":"0001860008","reported_name":"Telman Deborah H","relationship":{"officer":true,"officer_title":"EVP, Corporate Affairs & GC"}}],"security":"Common Stock","published_at":"2025-04-28T17:24:48.000Z","date":"2025-04-25","kind":"exercise","planned":false,"acquired":true,"shares":514,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."}],"balance_after":37076,"source":{"system":"sec-edgar","filing":"0001127602-25-012668","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760225012668/form4.xml","form_type":"4"}},{"id":324063,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15049,"kind":"person","name":"Telman Deborah H","position":1,"cik":"0001860008","reported_name":"Telman Deborah H","relationship":{"officer":true,"officer_title":"EVP, Corporate Affairs & GC"}}],"security":"Restricted Stock Unit","published_at":"2025-03-12T23:08:15.000Z","date":"2025-03-10","kind":"grant","planned":false,"acquired":true,"shares":7680,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":32216,"derivative":{"underlying":"Common Stock","underlying_shares":7680},"source":{"system":"sec-edgar","filing":"0001127602-25-009290","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760225009290/form4.xml","form_type":"4"}},{"id":324062,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15049,"kind":"person","name":"Telman Deborah H","position":1,"cik":"0001860008","reported_name":"Telman Deborah H","relationship":{"officer":true,"officer_title":"EVP, Corporate Affairs & GC"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2025-03-12T23:08:15.000Z","date":"2025-03-10","kind":"grant","planned":false,"acquired":true,"shares":33940,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The options have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":33940,"derivative":{"exercise_price":117.21,"expiration_date":"2035-03-10","underlying":"Common Stock","underlying_shares":33940},"source":{"system":"sec-edgar","filing":"0001127602-25-009290","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760225009290/form4.xml","form_type":"4"}},{"id":324061,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15049,"kind":"person","name":"Telman Deborah H","position":1,"cik":"0001860008","reported_name":"Telman Deborah H","relationship":{"officer":true,"officer_title":"EVP, Corporate Affairs & GC"}}],"security":"Restricted Stock Unit","published_at":"2025-03-12T23:08:15.000Z","date":"2025-03-10","kind":"exercise","planned":false,"acquired":false,"shares":3343,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":24356,"derivative":{"underlying":"Common Stock","underlying_shares":3343},"source":{"system":"sec-edgar","filing":"0001127602-25-009290","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760225009290/form4.xml","form_type":"4"}},{"id":324060,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15049,"kind":"person","name":"Telman Deborah H","position":1,"cik":"0001860008","reported_name":"Telman Deborah H","relationship":{"officer":true,"officer_title":"EVP, Corporate Affairs & GC"}}],"security":"Common Stock","published_at":"2025-03-12T23:08:15.000Z","date":"2025-03-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":1130,"price":117.21,"value":132447.3,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance adjusted to reflect shares acquired under the Gilead Sciences, Inc. Employee Stock Purchase Plan."}],"balance_after":36562,"source":{"system":"sec-edgar","filing":"0001127602-25-009290","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760225009290/form4.xml","form_type":"4"}},{"id":324059,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15049,"kind":"person","name":"Telman Deborah H","position":1,"cik":"0001860008","reported_name":"Telman Deborah H","relationship":{"officer":true,"officer_title":"EVP, Corporate Affairs & GC"}}],"security":"Common Stock","published_at":"2025-03-12T23:08:15.000Z","date":"2025-03-10","kind":"exercise","planned":false,"acquired":true,"shares":3343,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."}],"balance_after":37692,"source":{"system":"sec-edgar","filing":"0001127602-25-009290","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760225009290/form4.xml","form_type":"4"}},{"id":326483,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15049,"kind":"person","name":"Telman Deborah H","position":1,"cik":"0001860008","reported_name":"Telman Deborah H","relationship":{"officer":true,"officer_title":"EVP, Corporate Affairs & GC"}}],"security":"Common Stock","published_at":"2025-02-06T21:21:22.000Z","date":"2025-02-04","kind":"grant","planned":false,"acquired":true,"shares":12371,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of the Issuer's common stock subject to specific tranches of the performance share awards made to the Reporting person on March 10, 2023 and March 10,2024.  Such tranches of shares were subject to both performance-vesting and service-vesting requirements.  The performance vesting requirement was satisfied on the date reported in Column 2 above upon certification of the performance goal attainment by the Compensation and Talent Committee of the Issuer's Board of Directors.  However, the shares will not be issued to the Reporting person until the requisite continuing service requirements are met."}],"balance_after":34011,"source":{"system":"sec-edgar","filing":"0001127602-25-003389","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760225003389/form4.xml","form_type":"4"}},{"id":326949,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15049,"kind":"person","name":"Telman Deborah H","position":1,"cik":"0001860008","reported_name":"Telman Deborah H","relationship":{"officer":true,"officer_title":"EVP, Corporate Affairs & GC"}}],"security":"Restricted Stock Unit","published_at":"2025-01-27T22:47:59.000Z","date":"2025-01-25","kind":"exercise","planned":false,"acquired":false,"shares":515,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant.  The balance will vest 6.25% quarterly thereafter until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant.  The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":27879,"derivative":{"underlying":"Common Stock","underlying_shares":515},"source":{"system":"sec-edgar","filing":"0001127602-25-002030","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760225002030/form4.xml","form_type":"4"}},{"id":326948,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15049,"kind":"person","name":"Telman Deborah H","position":1,"cik":"0001860008","reported_name":"Telman Deborah H","relationship":{"officer":true,"officer_title":"EVP, Corporate Affairs & GC"}}],"security":"Common Stock","published_at":"2025-01-27T22:47:59.000Z","date":"2025-01-25","kind":"tax_withholding","planned":false,"acquired":false,"shares":187,"price":93.07,"value":17404.09,"ownership":{"direct":true},"balance_after":21640,"source":{"system":"sec-edgar","filing":"0001127602-25-002030","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760225002030/form4.xml","form_type":"4"}},{"id":326947,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15049,"kind":"person","name":"Telman Deborah H","position":1,"cik":"0001860008","reported_name":"Telman Deborah H","relationship":{"officer":true,"officer_title":"EVP, Corporate Affairs & GC"}}],"security":"Common Stock","published_at":"2025-01-27T22:47:59.000Z","date":"2025-01-25","kind":"exercise","planned":false,"acquired":true,"shares":515,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."}],"balance_after":21827,"source":{"system":"sec-edgar","filing":"0001127602-25-002030","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760225002030/form4.xml","form_type":"4"}},{"id":328464,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15049,"kind":"person","name":"Telman Deborah H","position":1,"cik":"0001860008","reported_name":"Telman Deborah H","relationship":{"officer":true,"officer_title":"EVP, Corporate Affairs & GC"}}],"security":"Restricted Stock Unit","published_at":"2024-12-12T00:51:40.000Z","date":"2024-12-10","kind":"exercise","planned":false,"acquired":false,"shares":639,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant.  The balance will vest 6.25% quarterly thereafter until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant.  The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":28394,"derivative":{"underlying":"Common Stock","underlying_shares":639},"source":{"system":"sec-edgar","filing":"0001127602-24-029181","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760224029181/form4.xml","form_type":"4"}},{"id":328463,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15049,"kind":"person","name":"Telman Deborah H","position":1,"cik":"0001860008","reported_name":"Telman Deborah H","relationship":{"officer":true,"officer_title":"EVP, Corporate Affairs & GC"}}],"security":"Common Stock","published_at":"2024-12-12T00:51:40.000Z","date":"2024-12-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":306,"price":92.34,"value":28256.04,"ownership":{"direct":true},"balance_after":21312,"source":{"system":"sec-edgar","filing":"0001127602-24-029181","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760224029181/form4.xml","form_type":"4"}},{"id":328462,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15049,"kind":"person","name":"Telman Deborah H","position":1,"cik":"0001860008","reported_name":"Telman Deborah H","relationship":{"officer":true,"officer_title":"EVP, Corporate Affairs & GC"}}],"security":"Common Stock","published_at":"2024-12-12T00:51:40.000Z","date":"2024-12-10","kind":"exercise","planned":false,"acquired":true,"shares":639,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."}],"balance_after":21618,"source":{"system":"sec-edgar","filing":"0001127602-24-029181","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760224029181/form4.xml","form_type":"4"}},{"id":329897,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15049,"kind":"person","name":"Telman Deborah H","position":1,"cik":"0001860008","reported_name":"Telman Deborah H","relationship":{"officer":true,"officer_title":"EVP, Corporate Affairs & GC"}}],"security":"Restricted Stock Unit","published_at":"2024-10-28T19:09:29.000Z","date":"2024-10-25","kind":"exercise","planned":false,"acquired":false,"shares":514,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant.  The balance will vest 6.25% quarterly thereafter until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant.  The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":29033,"derivative":{"underlying":"Common Stock","underlying_shares":514},"source":{"system":"sec-edgar","filing":"0001127602-24-026017","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760224026017/form4.xml","form_type":"4"}},{"id":329896,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15049,"kind":"person","name":"Telman Deborah H","position":1,"cik":"0001860008","reported_name":"Telman Deborah H","relationship":{"officer":true,"officer_title":"EVP, Corporate Affairs & GC"}}],"security":"Common Stock","published_at":"2024-10-28T19:09:29.000Z","date":"2024-10-25","kind":"tax_withholding","planned":false,"acquired":false,"shares":242,"price":89,"value":21538.0,"ownership":{"direct":true},"balance_after":20979,"source":{"system":"sec-edgar","filing":"0001127602-24-026017","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760224026017/form4.xml","form_type":"4"}},{"id":329895,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15049,"kind":"person","name":"Telman Deborah H","position":1,"cik":"0001860008","reported_name":"Telman Deborah H","relationship":{"officer":true,"officer_title":"EVP, Corporate Affairs & GC"}}],"security":"Common Stock","published_at":"2024-10-28T19:09:29.000Z","date":"2024-10-25","kind":"exercise","planned":false,"acquired":true,"shares":514,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."}],"balance_after":21221,"source":{"system":"sec-edgar","filing":"0001127602-24-026017","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760224026017/form4.xml","form_type":"4"}},{"id":330820,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15049,"kind":"person","name":"Telman Deborah H","position":1,"cik":"0001860008","reported_name":"Telman Deborah H","relationship":{"officer":true,"officer_title":"EVP, Corporate Affairs & GC"}}],"security":"Restricted Stock Unit","published_at":"2024-09-11T23:41:25.000Z","date":"2024-09-10","kind":"exercise","planned":false,"acquired":false,"shares":639,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant.  The balance will vest 6.25% quarterly thereafter until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant.  The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":29547,"derivative":{"underlying":"Common Stock","underlying_shares":639},"source":{"system":"sec-edgar","filing":"0001127602-24-023825","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760224023825/form4.xml","form_type":"4"}},{"id":330819,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15049,"kind":"person","name":"Telman Deborah H","position":1,"cik":"0001860008","reported_name":"Telman Deborah H","relationship":{"officer":true,"officer_title":"EVP, Corporate Affairs & GC"}}],"security":"Common Stock","published_at":"2024-09-11T23:41:25.000Z","date":"2024-09-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":307,"price":81.44,"value":25002.08,"ownership":{"direct":true},"balance_after":20707,"source":{"system":"sec-edgar","filing":"0001127602-24-023825","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760224023825/form4.xml","form_type":"4"}},{"id":330818,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15049,"kind":"person","name":"Telman Deborah H","position":1,"cik":"0001860008","reported_name":"Telman Deborah H","relationship":{"officer":true,"officer_title":"EVP, Corporate Affairs & GC"}}],"security":"Common Stock","published_at":"2024-09-11T23:41:25.000Z","date":"2024-09-10","kind":"exercise","planned":false,"acquired":true,"shares":639,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."}],"balance_after":21014,"source":{"system":"sec-edgar","filing":"0001127602-24-023825","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760224023825/form4.xml","form_type":"4"}},{"id":331884,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15049,"kind":"person","name":"Telman Deborah H","position":1,"cik":"0001860008","reported_name":"Telman Deborah H","relationship":{"officer":true,"officer_title":"EVP, Corporate Affairs & GC"}}],"security":"Restricted Stock Unit","published_at":"2024-07-26T21:28:51.000Z","date":"2024-07-25","kind":"exercise","planned":false,"acquired":false,"shares":8230,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units have a three year vesting schedule. 33.33% will vest on each yearly anniversary of the date of the grant until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units have a three year vesting schedule. 33.33% will vest on each yearly anniversary of the date of the grant until fully vested."}],"balance_after":30186,"derivative":{"underlying":"Common Stock","underlying_shares":8230},"source":{"system":"sec-edgar","filing":"0001127602-24-021048","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760224021048/form4.xml","form_type":"4"}},{"id":331883,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15049,"kind":"person","name":"Telman Deborah H","position":1,"cik":"0001860008","reported_name":"Telman Deborah H","relationship":{"officer":true,"officer_title":"EVP, Corporate Affairs & GC"}}],"security":"Restricted Stock Unit","published_at":"2024-07-26T21:28:51.000Z","date":"2024-07-25","kind":"exercise","planned":false,"acquired":false,"shares":514,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant.  The balance will vest 6.25% quarterly thereafter until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant.  The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":38416,"derivative":{"underlying":"Common Stock","underlying_shares":514},"source":{"system":"sec-edgar","filing":"0001127602-24-021048","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760224021048/form4.xml","form_type":"4"}},{"id":331882,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15049,"kind":"person","name":"Telman Deborah H","position":1,"cik":"0001860008","reported_name":"Telman Deborah H","relationship":{"officer":true,"officer_title":"EVP, Corporate Affairs & GC"}}],"security":"Common Stock","published_at":"2024-07-26T21:28:51.000Z","date":"2024-07-25","kind":"exercise","planned":false,"acquired":true,"shares":8230,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."}],"balance_after":20375,"source":{"system":"sec-edgar","filing":"0001127602-24-021048","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760224021048/form4.xml","form_type":"4"}},{"id":331881,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15049,"kind":"person","name":"Telman Deborah H","position":1,"cik":"0001860008","reported_name":"Telman Deborah H","relationship":{"officer":true,"officer_title":"EVP, Corporate Affairs & GC"}}],"security":"Common Stock","published_at":"2024-07-26T21:28:51.000Z","date":"2024-07-25","kind":"exercise","planned":false,"acquired":true,"shares":514,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."}],"balance_after":12145,"source":{"system":"sec-edgar","filing":"0001127602-24-021048","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760224021048/form4.xml","form_type":"4"}},{"id":331880,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15049,"kind":"person","name":"Telman Deborah H","position":1,"cik":"0001860008","reported_name":"Telman Deborah H","relationship":{"officer":true,"officer_title":"EVP, Corporate Affairs & GC"}}],"security":"Common Stock","published_at":"2024-07-26T21:28:51.000Z","date":"2024-07-25","kind":"tax_withholding","planned":false,"acquired":false,"shares":2917,"price":76.51,"value":223179.67,"ownership":{"direct":true},"balance_after":11631,"source":{"system":"sec-edgar","filing":"0001127602-24-021048","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760224021048/form4.xml","form_type":"4"}},{"id":332917,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15049,"kind":"person","name":"Telman Deborah H","position":1,"cik":"0001860008","reported_name":"Telman Deborah H","relationship":{"officer":true,"officer_title":"EVP, Corporate Affairs & GC"}}],"security":"Restricted Stock Unit","published_at":"2024-06-11T23:12:00.000Z","date":"2024-06-10","kind":"exercise","planned":false,"acquired":false,"shares":638,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant.  The balance will vest 6.25% quarterly thereafter until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant.  The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":38930,"derivative":{"underlying":"Common Stock","underlying_shares":638},"source":{"system":"sec-edgar","filing":"0001127602-24-018411","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760224018411/form4.xml","form_type":"4"}},{"id":332916,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15049,"kind":"person","name":"Telman Deborah H","position":1,"cik":"0001860008","reported_name":"Telman Deborah H","relationship":{"officer":true,"officer_title":"EVP, Corporate Affairs & GC"}}],"security":"Common Stock","published_at":"2024-06-11T23:12:00.000Z","date":"2024-06-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":204,"price":65.25,"value":13311.0,"ownership":{"direct":true},"balance_after":14548,"source":{"system":"sec-edgar","filing":"0001127602-24-018411","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760224018411/form4.xml","form_type":"4"}},{"id":332915,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15049,"kind":"person","name":"Telman Deborah H","position":1,"cik":"0001860008","reported_name":"Telman Deborah H","relationship":{"officer":true,"officer_title":"EVP, Corporate Affairs & GC"}}],"security":"Common Stock","published_at":"2024-06-11T23:12:00.000Z","date":"2024-06-10","kind":"exercise","planned":false,"acquired":true,"shares":638,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."}],"balance_after":14752,"source":{"system":"sec-edgar","filing":"0001127602-24-018411","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760224018411/form4.xml","form_type":"4"}},{"id":1517689,"issuer":{"id":2704,"kind":"organization","name":"AtriCure, Inc.","symbol":"ATRC"},"owners":[{"id":15049,"kind":"person","name":"Telman Deborah H","position":1,"cik":"0001860008","reported_name":"Telman Deborah H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-14T21:05:11.000Z","date":"2024-05-13","kind":"grant","planned":false,"acquired":true,"shares":7788,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2023 Stock Incentive Plan. The shares will vest upon the one-year anniversary of the grant date."}],"balance_after":16783,"source":{"system":"sec-edgar","filing":"0001323885-24-000080","document":"wk-form4_1715720687.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1860008/000132388524000080/wk-form4_1715720687.xml","form_type":"4"}},{"id":334428,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15049,"kind":"person","name":"Telman Deborah H","position":1,"cik":"0001860008","reported_name":"Telman Deborah H","relationship":{"officer":true,"officer_title":"EVP, Corporate Affairs & GC"}}],"security":"Restricted Stock Unit","published_at":"2024-04-26T20:30:43.000Z","date":"2024-04-25","kind":"exercise","planned":false,"acquired":false,"shares":515,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant.  The balance will vest 6.25% quarterly thereafter until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant.  The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":39568,"derivative":{"underlying":"Common Stock","underlying_shares":515},"source":{"system":"sec-edgar","filing":"0001127602-24-013462","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760224013462/form4.xml","form_type":"4"}},{"id":334427,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15049,"kind":"person","name":"Telman Deborah H","position":1,"cik":"0001860008","reported_name":"Telman Deborah H","relationship":{"officer":true,"officer_title":"EVP, Corporate Affairs & GC"}}],"security":"Common Stock","published_at":"2024-04-26T20:30:43.000Z","date":"2024-04-25","kind":"tax_withholding","planned":false,"acquired":false,"shares":158,"price":65.27,"value":10312.66,"ownership":{"direct":true},"balance_after":14114,"source":{"system":"sec-edgar","filing":"0001127602-24-013462","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760224013462/form4.xml","form_type":"4"}},{"id":334426,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15049,"kind":"person","name":"Telman Deborah H","position":1,"cik":"0001860008","reported_name":"Telman Deborah H","relationship":{"officer":true,"officer_title":"EVP, Corporate Affairs & GC"}}],"security":"Common Stock","published_at":"2024-04-26T20:30:43.000Z","date":"2024-04-25","kind":"exercise","planned":false,"acquired":true,"shares":515,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."}],"balance_after":14272,"source":{"system":"sec-edgar","filing":"0001127602-24-013462","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760224013462/form4.xml","form_type":"4"}},{"id":337490,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15049,"kind":"person","name":"Telman Deborah H","position":1,"cik":"0001860008","reported_name":"Telman Deborah H","relationship":{"officer":true,"officer_title":"EVP, Corporate Affairs & GC"}}],"security":"Restricted Stock Unit","published_at":"2024-03-12T20:19:08.000Z","date":"2024-03-10","kind":"grant","planned":false,"acquired":true,"shares":10815,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant.  The balance will vest 6.25% quarterly thereafter until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant.  The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":40083,"derivative":{"underlying":"Common Stock","underlying_shares":10815},"source":{"system":"sec-edgar","filing":"0001127602-24-009742","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760224009742/form4.xml","form_type":"4"}},{"id":337489,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15049,"kind":"person","name":"Telman Deborah H","position":1,"cik":"0001860008","reported_name":"Telman Deborah H","relationship":{"officer":true,"officer_title":"EVP, Corporate Affairs & GC"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2024-03-12T20:19:08.000Z","date":"2024-03-10","kind":"grant","planned":false,"acquired":true,"shares":54980,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to the option have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":54980,"derivative":{"exercise_price":75.12,"expiration_date":"2034-03-10","underlying":"Common Stock","underlying_shares":54980},"source":{"system":"sec-edgar","filing":"0001127602-24-009742","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760224009742/form4.xml","form_type":"4"}},{"id":337488,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15049,"kind":"person","name":"Telman Deborah H","position":1,"cik":"0001860008","reported_name":"Telman Deborah H","relationship":{"officer":true,"officer_title":"EVP, Corporate Affairs & GC"}}],"security":"Restricted Stock Unit","published_at":"2024-03-12T20:19:08.000Z","date":"2024-03-10","kind":"exercise","planned":false,"acquired":false,"shares":2555,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant.  The balance will vest 6.25% quarterly thereafter until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant.  The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":29268,"derivative":{"underlying":"Common Stock","underlying_shares":2555},"source":{"system":"sec-edgar","filing":"0001127602-24-009742","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760224009742/form4.xml","form_type":"4"}},{"id":337487,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15049,"kind":"person","name":"Telman Deborah H","position":1,"cik":"0001860008","reported_name":"Telman Deborah H","relationship":{"officer":true,"officer_title":"EVP, Corporate Affairs & GC"}}],"security":"Common Stock","published_at":"2024-03-12T20:19:08.000Z","date":"2024-03-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":846,"price":75.12,"value":63551.52,"ownership":{"direct":true},"balance_after":13757,"source":{"system":"sec-edgar","filing":"0001127602-24-009742","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760224009742/form4.xml","form_type":"4"}},{"id":337486,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15049,"kind":"person","name":"Telman Deborah H","position":1,"cik":"0001860008","reported_name":"Telman Deborah H","relationship":{"officer":true,"officer_title":"EVP, Corporate Affairs & GC"}}],"security":"Common Stock","published_at":"2024-03-12T20:19:08.000Z","date":"2024-03-10","kind":"exercise","planned":false,"acquired":true,"shares":2555,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance adjusted to reflect shares acquired under the Gilead Sciences, Inc. Employee Stock Purchase Plan."}],"balance_after":14603,"source":{"system":"sec-edgar","filing":"0001127602-24-009742","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760224009742/form4.xml","form_type":"4"}},{"id":341397,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15049,"kind":"person","name":"Telman Deborah H","position":1,"cik":"0001860008","reported_name":"Telman Deborah H","relationship":{"officer":true,"officer_title":"EVP, Corporate Affairs & GC"}}],"security":"Common Stock","published_at":"2024-02-02T19:19:09.000Z","date":"2024-01-31","kind":"grant","planned":false,"acquired":true,"shares":4646,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of the Issuer's common stock subject to specific tranches of the performance share awards made to the Reporting person on March 10, 2023.  Such tranches of shares were subject to both performance-vesting and service-vesting requirements.  The performance vesting requirement was satisfied on the date reported in Column 2 above upon certification of the performance goal attainment by the Compensation and Talent Committee of the Issuer's Board of Directors.  However, the shares will not be issued to the Reporting person until the requisite continuing service requirements are met."}],"balance_after":11728,"source":{"system":"sec-edgar","filing":"0001127602-24-003028","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760224003028/form4.xml","form_type":"4"}},{"id":341724,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15049,"kind":"person","name":"Telman Deborah H","position":1,"cik":"0001860008","reported_name":"Telman Deborah H","relationship":{"officer":true,"officer_title":"EVP, Corporate Affairs & GC"}}],"security":"Restricted Stock Unit","published_at":"2024-01-26T21:31:43.000Z","date":"2024-01-25","kind":"exercise","planned":false,"acquired":false,"shares":514,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant.  The balance will vest 6.25% quarterly thereafter until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant.  The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":31823,"derivative":{"underlying":"Common Stock","underlying_shares":514},"source":{"system":"sec-edgar","filing":"0001127602-24-002300","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760224002300/form4.xml","form_type":"4"}},{"id":341723,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15049,"kind":"person","name":"Telman Deborah H","position":1,"cik":"0001860008","reported_name":"Telman Deborah H","relationship":{"officer":true,"officer_title":"EVP, Corporate Affairs & GC"}}],"security":"Common Stock","published_at":"2024-01-26T21:31:43.000Z","date":"2024-01-25","kind":"tax_withholding","planned":false,"acquired":false,"shares":194,"price":80.23,"value":15564.62,"ownership":{"direct":true},"balance_after":7082,"source":{"system":"sec-edgar","filing":"0001127602-24-002300","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760224002300/form4.xml","form_type":"4"}},{"id":341722,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15049,"kind":"person","name":"Telman Deborah H","position":1,"cik":"0001860008","reported_name":"Telman Deborah H","relationship":{"officer":true,"officer_title":"EVP, Corporate Affairs & GC"}}],"security":"Common Stock","published_at":"2024-01-26T21:31:43.000Z","date":"2024-01-25","kind":"exercise","planned":false,"acquired":true,"shares":514,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."}],"balance_after":7276,"source":{"system":"sec-edgar","filing":"0001127602-24-002300","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760224002300/form4.xml","form_type":"4"}},{"id":344936,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15049,"kind":"person","name":"Telman Deborah H","position":1,"cik":"0001860008","reported_name":"Telman Deborah H","relationship":{"officer":true,"officer_title":"EVP, Corporate Affairs & GC"}}],"security":"Restricted Stock Unit","published_at":"2023-10-26T21:56:50.000Z","date":"2023-10-25","kind":"exercise","planned":false,"acquired":false,"shares":514,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant.  The balance will vest 6.25% quarterly thereafter until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant.  The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":32337,"derivative":{"underlying":"Common Stock","underlying_shares":514},"source":{"system":"sec-edgar","filing":"0001127602-23-026281","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760223026281/form4.xml","form_type":"4"}},{"id":344935,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15049,"kind":"person","name":"Telman Deborah H","position":1,"cik":"0001860008","reported_name":"Telman Deborah H","relationship":{"officer":true,"officer_title":"EVP, Corporate Affairs & GC"}}],"security":"Common Stock","published_at":"2023-10-26T21:56:50.000Z","date":"2023-10-25","kind":"tax_withholding","planned":false,"acquired":false,"shares":243,"price":78.39,"value":19048.77,"ownership":{"direct":true},"balance_after":6762,"source":{"system":"sec-edgar","filing":"0001127602-23-026281","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760223026281/form4.xml","form_type":"4"}},{"id":344934,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15049,"kind":"person","name":"Telman Deborah H","position":1,"cik":"0001860008","reported_name":"Telman Deborah H","relationship":{"officer":true,"officer_title":"EVP, Corporate Affairs & GC"}}],"security":"Common Stock","published_at":"2023-10-26T21:56:50.000Z","date":"2023-10-25","kind":"exercise","planned":false,"acquired":true,"shares":514,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."}],"balance_after":7005,"source":{"system":"sec-edgar","filing":"0001127602-23-026281","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760223026281/form4.xml","form_type":"4"}},{"id":347154,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15049,"kind":"person","name":"Telman Deborah H","position":1,"cik":"0001860008","reported_name":"Telman Deborah H","relationship":{"officer":true,"officer_title":"EVP, Corporate Affairs & GC"}}],"security":"Restricted Stock Unit","published_at":"2023-07-26T20:53:55.000Z","date":"2023-07-25","kind":"exercise","planned":false,"acquired":false,"shares":2058,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":32851,"derivative":{"underlying":"Common Stock","underlying_shares":2058},"source":{"system":"sec-edgar","filing":"0001127602-23-021338","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760223021338/form4.xml","form_type":"4"}},{"id":347153,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15049,"kind":"person","name":"Telman Deborah H","position":1,"cik":"0001860008","reported_name":"Telman Deborah H","relationship":{"officer":true,"officer_title":"EVP, Corporate Affairs & GC"}}],"security":"Restricted Stock Unit","published_at":"2023-07-26T20:53:55.000Z","date":"2023-07-25","kind":"exercise","planned":false,"acquired":false,"shares":8231,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units have a three year vesting schedule. 33.33% will vest on each yearly anniversary of the date of grant until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units have a three year vesting schedule. 33.33% will vest on each yearly anniversary of the date of grant until fully vested."}],"balance_after":34909,"derivative":{"underlying":"Common Stock","underlying_shares":8231},"source":{"system":"sec-edgar","filing":"0001127602-23-021338","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760223021338/form4.xml","form_type":"4"}},{"id":347152,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15049,"kind":"person","name":"Telman Deborah H","position":1,"cik":"0001860008","reported_name":"Telman Deborah H","relationship":{"officer":true,"officer_title":"EVP, Corporate Affairs & GC"}}],"security":"Common Stock","published_at":"2023-07-26T20:53:55.000Z","date":"2023-07-25","kind":"exercise","planned":false,"acquired":true,"shares":2058,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."}],"balance_after":6491,"source":{"system":"sec-edgar","filing":"0001127602-23-021338","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760223021338/form4.xml","form_type":"4"}},{"id":347151,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15049,"kind":"person","name":"Telman Deborah H","position":1,"cik":"0001860008","reported_name":"Telman Deborah H","relationship":{"officer":true,"officer_title":"EVP, Corporate Affairs & GC"}}],"security":"Common Stock","published_at":"2023-07-26T20:53:55.000Z","date":"2023-07-25","kind":"tax_withholding","planned":false,"acquired":false,"shares":4174,"price":77.23,"value":322358.02,"ownership":{"direct":true},"balance_after":4433,"source":{"system":"sec-edgar","filing":"0001127602-23-021338","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760223021338/form4.xml","form_type":"4"}},{"id":347150,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15049,"kind":"person","name":"Telman Deborah H","position":1,"cik":"0001860008","reported_name":"Telman Deborah H","relationship":{"officer":true,"officer_title":"EVP, Corporate Affairs & GC"}}],"security":"Common Stock","published_at":"2023-07-26T20:53:55.000Z","date":"2023-07-25","kind":"exercise","planned":false,"acquired":true,"shares":8231,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."}],"balance_after":8607,"source":{"system":"sec-edgar","filing":"0001127602-23-021338","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760223021338/form4.xml","form_type":"4"}},{"id":1876729,"issuer":{"id":2704,"kind":"organization","name":"AtriCure, Inc.","symbol":"ATRC"},"owners":[{"id":15049,"kind":"person","name":"Telman Deborah H","position":1,"cik":"0001860008","reported_name":"Telman Deborah H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-26T20:19:30.000Z","date":"2023-05-25","kind":"grant","planned":false,"acquired":true,"shares":3186,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2023 Stock Incentive Plan. The shares will vest upon the one-year anniversary of the grant date."}],"balance_after":8995,"source":{"system":"sec-edgar","filing":"0001323885-23-000061","document":"wk-form4_1685132316.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1860008/000132388523000061/wk-form4_1685132316.xml","form_type":"4"}},{"id":351530,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15049,"kind":"person","name":"Telman Deborah H","position":1,"cik":"0001860008","reported_name":"Telman Deborah H","relationship":{"officer":true,"officer_title":"EVP, Corporate Affairs & GC"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2023-03-14T00:50:23.000Z","date":"2023-03-10","kind":"grant","acquired":true,"shares":46605,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the option have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":46605,"derivative":{"exercise_price":79.5,"expiration_date":"2033-03-10","underlying":"Common Stock","underlying_shares":46605},"source":{"system":"sec-edgar","filing":"0001127602-23-009978","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760223009978/form4.xml","form_type":"4"}},{"id":351529,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15049,"kind":"person","name":"Telman Deborah H","position":1,"cik":"0001860008","reported_name":"Telman Deborah H","relationship":{"officer":true,"officer_title":"EVP, Corporate Affairs & GC"}}],"security":"Restricted Stock Unit","published_at":"2023-03-14T00:50:23.000Z","date":"2023-03-10","kind":"grant","acquired":true,"shares":10220,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":43140,"derivative":{"underlying":"Common Stock","underlying_shares":10220},"source":{"system":"sec-edgar","filing":"0001127602-23-009978","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760223009978/form4.xml","form_type":"4"}},{"id":352652,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15049,"kind":"person","name":"Telman Deborah H","position":1,"cik":"0001860008","reported_name":"Telman Deborah H","relationship":{"officer":true,"officer_title":"EVP, Corporate Affairs & GC"}}],"security":"Common Stock","published_at":"2023-02-23T21:08:19.000Z","date":"2023-02-15","kind":"grant","acquired":true,"shares":376,"price":56.3805,"value":21199.068,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person is voluntarily reporting the acquisition of shares of the Issuer's common stock pursuant to the Gilead Sciences, Inc. Employee Stock Purchase Plan (\"ESPP\") for the ESPP purchase period of August 16, 2022 through February 15, 2023.  The transaction is exempt under Rule 16b-3(c)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the Issuer's common stock on August 16, 2022."}],"balance_after":376,"source":{"system":"sec-edgar","filing":"0001127602-23-006757","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760223006757/form4.xml","form_type":"4"}},{"id":2253739,"issuer":{"id":2704,"kind":"organization","name":"AtriCure, Inc.","symbol":"ATRC"},"owners":[{"id":15049,"kind":"person","name":"Telman Deborah H","position":1,"cik":"0001860008","reported_name":"Telman Deborah H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-27T13:03:16.000Z","date":"2022-05-25","kind":"grant","acquired":true,"shares":3564,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2014 Stock Incentive Plan. The shares will vest upon the one-year anniversary of the grant date."}],"balance_after":5809,"source":{"system":"sec-edgar","filing":"0001323885-22-000073","document":"wf-form4_165365658158055.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1860008/000132388522000073/wf-form4_165365658158055.xml","form_type":"4"}},{"id":2280968,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":15049,"kind":"person","name":"Telman Deborah H","position":1,"cik":"0001860008","reported_name":"Telman Deborah H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP GC & Corporate Secretary"}}],"security":"Restricted Stock Units","published_at":"2022-05-06T00:52:25.000Z","date":"2022-05-04","kind":"exercise","acquired":false,"shares":4431,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Organon & Co. (\"Organon\") common stock for each RSU."},{"field":"shares","element":"transactionShares","label":"F2","text":"The amount of the RSUs has been slightly adjusted from the Reporting Person's Form 4, dated June 4, 2021, based on the finalization of certain calculations."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On May 4, 2022, one-third of the RSUs vested with the remaining RSUs to vest in two equal installments on May 4, 2023 and May 4, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On May 4, 2022, one-third of the RSUs vested with the remaining RSUs to vest in two equal installments on May 4, 2023 and May 4, 2024."}],"balance_after":4431,"derivative":{"exercise_date":"2022-05-04","expiration_date":"2024-05-04","underlying":"Common Stock","underlying_shares":4431},"source":{"system":"sec-edgar","filing":"0001104659-22-056633","document":"tm2214603-9_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1860008/000110465922056633/tm2214603-9_4seq1.xml","form_type":"4"}},{"id":2280967,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":15049,"kind":"person","name":"Telman Deborah H","position":1,"cik":"0001860008","reported_name":"Telman Deborah H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP GC & Corporate Secretary"}}],"security":"Common Stock","published_at":"2022-05-06T00:52:25.000Z","date":"2022-05-04","kind":"tax_withholding","acquired":false,"shares":1299,"price":32.44,"value":42139.56,"ownership":{"direct":true},"balance_after":7688,"source":{"system":"sec-edgar","filing":"0001104659-22-056633","document":"tm2214603-9_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1860008/000110465922056633/tm2214603-9_4seq1.xml","form_type":"4"}},{"id":2280966,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":15049,"kind":"person","name":"Telman Deborah H","position":1,"cik":"0001860008","reported_name":"Telman Deborah H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP GC & Corporate Secretary"}}],"security":"Common Stock","published_at":"2022-05-06T00:52:25.000Z","date":"2022-05-04","kind":"exercise","acquired":true,"shares":4431,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Organon & Co. (\"Organon\") common stock for each RSU."}],"balance_after":8987,"source":{"system":"sec-edgar","filing":"0001104659-22-056633","document":"tm2214603-9_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1860008/000110465922056633/tm2214603-9_4seq1.xml","form_type":"4"}},{"id":2308752,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":15049,"kind":"person","name":"Telman Deborah H","position":1,"cik":"0001860008","reported_name":"Telman Deborah H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Gen Counsel & Corp Sec"}}],"security":"Stock Option (right to buy)","published_at":"2022-04-04T22:13:35.000Z","date":"2022-03-31","kind":"grant","acquired":true,"shares":39682,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Reporting Person was granted stock options, which vest and become exercisable in three equal installments on March 31, 2023, March 31, 2024 and March 31, 2025."}],"balance_after":39682,"derivative":{"exercise_price":34.93,"exercise_date":"2023-03-31","expiration_date":"2032-03-29","underlying":"Common Stock","underlying_shares":39682},"source":{"system":"sec-edgar","filing":"0001104659-22-042366","document":"tm2211465-10_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1860008/000110465922042366/tm2211465-10_4seq1.xml","form_type":"4"}},{"id":2308751,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":15049,"kind":"person","name":"Telman Deborah H","position":1,"cik":"0001860008","reported_name":"Telman Deborah H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Gen Counsel & Corp Sec"}}],"security":"Restricted Stock Units","published_at":"2022-04-04T22:13:35.000Z","date":"2022-03-31","kind":"grant","acquired":true,"shares":12882,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Organon & Co. (\"Organon\") common stock for each RSU."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These RSUs vest and are distributed as shares of Organon common stock in three equal installments on March 31, 2023, March 31, 2024 and March 31, 2025."}],"balance_after":12882,"derivative":{"exercise_date":"2023-03-31","expiration_date":"2025-03-31","underlying":"Common Stock","underlying_shares":12882},"source":{"system":"sec-edgar","filing":"0001104659-22-042366","document":"tm2211465-10_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1860008/000110465922042366/tm2211465-10_4seq1.xml","form_type":"4"}},{"id":2596355,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":15049,"kind":"person","name":"Telman Deborah H","position":1,"cik":"0001860008","reported_name":"Telman Deborah H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Gen Counsel & Corp Sec"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-08-19T21:03:47.000Z","date":"2021-08-17","kind":"grant","acquired":true,"shares":22321,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in three equal installments on August 17, 2022, August 17, 2023 and August 17, 2024."}],"balance_after":22321,"derivative":{"exercise_price":35.38,"exercise_date":"2022-08-17","expiration_date":"2031-08-16","underlying":"Common Stock","underlying_shares":22321},"source":{"system":"sec-edgar","filing":"0000899243-21-033661","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1860008/000089924321033661/doc4.xml","form_type":"4"}},{"id":2610245,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":15049,"kind":"person","name":"Telman Deborah H","position":1,"cik":"0001860008","reported_name":"Telman Deborah H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP GC & Corporate Secretary"}}],"security":"Restricted Stock Units","published_at":"2021-08-09T20:47:41.000Z","date":"2021-08-05","kind":"exercise","acquired":true,"shares":6445,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Organon & Co. (\"Organon\") common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These restricted stock units vest and are distributed as shares of Organon common stock in three equal installments on August 5, 2021, August 5, 2022 and August 5, 2023."}],"balance_after":12892,"derivative":{"exercise_date":"2021-08-05","expiration_date":"2023-08-05","underlying":"Common Stock","underlying_shares":6445},"source":{"system":"sec-edgar","filing":"0000899243-21-032181","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1860008/000089924321032181/doc4.xml","form_type":"4"}},{"id":2610244,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":15049,"kind":"person","name":"Telman Deborah H","position":1,"cik":"0001860008","reported_name":"Telman Deborah H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP GC & Corporate Secretary"}}],"security":"Common Stock","published_at":"2021-08-09T20:47:41.000Z","date":"2021-08-05","kind":"tax_withholding","acquired":false,"shares":1889,"price":28.63,"value":54082.07,"ownership":{"direct":true},"balance_after":4556,"source":{"system":"sec-edgar","filing":"0000899243-21-032181","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1860008/000089924321032181/doc4.xml","form_type":"4"}},{"id":2610243,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":15049,"kind":"person","name":"Telman Deborah H","position":1,"cik":"0001860008","reported_name":"Telman Deborah H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP GC & Corporate Secretary"}}],"security":"Common Stock","published_at":"2021-08-09T20:47:41.000Z","date":"2021-08-05","kind":"exercise","acquired":true,"shares":6445,"price":28.63,"value":184520.35,"ownership":{"direct":true},"balance_after":6445,"source":{"system":"sec-edgar","filing":"0000899243-21-032181","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1860008/000089924321032181/doc4.xml","form_type":"4"}},{"id":2664160,"issuer":{"id":2704,"kind":"organization","name":"AtriCure, Inc.","symbol":"ATRC"},"owners":[{"id":15049,"kind":"person","name":"Telman Deborah H","position":1,"cik":"0001860008","reported_name":"Telman Deborah H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-17T12:33:35.000Z","date":"2021-06-15","kind":"grant","acquired":true,"shares":2245,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2014 Stock Incentive Plan. The shares will vest 33% annually over three years from date of grant."}],"balance_after":2245,"source":{"system":"sec-edgar","filing":"0001209191-21-041246","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1860008/000120919121041246/doc4.xml","form_type":"4"}},{"id":2681213,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":15049,"kind":"person","name":"Telman Deborah H","position":1,"cik":"0001860008","reported_name":"Telman Deborah H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-05T01:17:36.000Z","date":"2021-06-02","kind":"grant","acquired":true,"shares":103095,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F7","text":"In connection with the Separation, each outstanding Merck stock option was converted into an award of options to purchase shares of Organon common stock pursuant to the terms of the employee matters agreement between Merck and Organon. The number of shares and exercise price of each option award was adjusted in a manner intended to preserve the aggregate intrinsic value of the original Merck stock option. The value reflects Organon's best estimate of the numbers using the currently available information and may be subject to adjustment following finalization of calculations."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The option vests and becomes exercisable in three equal installments on May 4, 2022, May 4, 2023 and May 4, 2024."}],"balance_after":103095,"derivative":{"exercise_price":36.11,"exercise_date":"2022-05-04","expiration_date":"2031-05-03","underlying":"Common Stock","underlying_shares":103095},"source":{"system":"sec-edgar","filing":"0000899243-21-022184","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1860008/000089924321022184/doc4.xml","form_type":"4"}},{"id":2681212,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":15049,"kind":"person","name":"Telman Deborah H","position":1,"cik":"0001860008","reported_name":"Telman Deborah H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Restricted Stock Units","published_at":"2021-06-05T01:17:36.000Z","date":"2021-06-02","kind":"grant","acquired":true,"shares":17624,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Organon & Co. (\"Organon\") common stock."},{"field":"kind","element":"transactionCoding","label":"F5","text":"In connection with the Separation, each outstanding Merck performance stock unit award was converted into a restricted stock unit award denominated in shares of Organon common stock pursuant to the terms of the employee matters agreement between Merck and Organon. The number of underlying shares was adjusted in a manner intended to preserve the aggregate intrinsic value of the original Merck performance stock unit award. The value reflects Organon's best estimate of the numbers using the currently available information and may be subject to adjustment following finalization of calculations."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"These restricted stock units vest and are distributed as shares of Organon common stock in a single installment on December 31, 2023."}],"balance_after":17624,"derivative":{"exercise_date":"2023-12-31","expiration_date":"2023-12-31","underlying":"Common Stock","underlying_shares":17624},"source":{"system":"sec-edgar","filing":"0000899243-21-022184","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1860008/000089924321022184/doc4.xml","form_type":"4"}},{"id":2681211,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":15049,"kind":"person","name":"Telman Deborah H","position":1,"cik":"0001860008","reported_name":"Telman Deborah H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Restricted Stock Units","published_at":"2021-06-05T01:17:36.000Z","date":"2021-06-02","kind":"grant","acquired":true,"shares":13296,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Organon & Co. (\"Organon\") common stock."},{"field":"kind","element":"transactionCoding","label":"F2","text":"In connection with the separation (the \"Separation\") of Organon from Merck & Co., Inc. (\"Merck\"), each outstanding Merck restricted stock unit award was converted into a restricted stock unit award denominated in shares of Organon common stock pursuant to the terms of the employee matters agreement between Merck and Organon. The number of underlying shares was adjusted in a manner intended to preserve the aggregate intrinsic value of the original Merck restricted stock unit award. The value reflects Organon's best estimate of the numbers using the currently available information and may be subject to adjustment following finalization of calculations."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These restricted stock units vest and are distributed as shares of Organon common stock in three equal installments on May 4, 2022, May 4, 2023 and May 4, 2024."}],"balance_after":13296,"derivative":{"exercise_date":"2022-05-04","expiration_date":"2024-05-04","underlying":"Common Stock","underlying_shares":13296},"source":{"system":"sec-edgar","filing":"0000899243-21-022184","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1860008/000089924321022184/doc4.xml","form_type":"4"}},{"id":2681210,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":15049,"kind":"person","name":"Telman Deborah H","position":1,"cik":"0001860008","reported_name":"Telman Deborah H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Restricted Stock Units","published_at":"2021-06-05T01:17:36.000Z","date":"2021-06-02","kind":"grant","acquired":true,"shares":19337,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Organon & Co. (\"Organon\") common stock."},{"field":"kind","element":"transactionCoding","label":"F2","text":"In connection with the separation (the \"Separation\") of Organon from Merck & Co., Inc. (\"Merck\"), each outstanding Merck restricted stock unit award was converted into a restricted stock unit award denominated in shares of Organon common stock pursuant to the terms of the employee matters agreement between Merck and Organon. The number of underlying shares was adjusted in a manner intended to preserve the aggregate intrinsic value of the original Merck restricted stock unit award. The value reflects Organon's best estimate of the numbers using the currently available information and may be subject to adjustment following finalization of calculations."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These restricted stock units vest and are distributed as shares of Organon common stock in three equal installments on August 5, 2021, August 5, 2022 and August 5, 2023."}],"balance_after":19337,"derivative":{"exercise_date":"2021-08-05","expiration_date":"2023-08-05","underlying":"Common Stock","underlying_shares":19337},"source":{"system":"sec-edgar","filing":"0000899243-21-022184","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1860008/000089924321022184/doc4.xml","form_type":"4"}}]}